SCHEMBL24486993

SCHEMBL24486993

O=C(Cc1cc(=O)oc2ccc(CNC(=O)ON3C(=O)CCC3=O)cc12)CS(=O)(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.35
▸ TSHR P16473 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.34
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ MTNR1A P48039 1/20 0.34
▸ MTNR1B P49286 1/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ PKM P14618 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ BCHE P06276 3/20 0.33
▸ USP2 O75604 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24486869 0.88 ALDH1A1 (0.36) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486871 0.85 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486958 0.85 TSHR (0.34) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486909 0.83 TSHR (0.33) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486955 0.81 ALDH1A1 (0.33) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24487003 0.80 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486912 0.80 ACHE (0.39) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486801 0.78 ALDH1A1 (0.38) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486952 0.78 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2
SCHEMBL24486956 0.78 ALDH1A1 (0.33) ALDH1A1TSHRNPSR1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, ST3GAL3 ALDH1A1 1650/4885TSHR 973/4885NPSR1 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback